VDAC1 and Miyoshi myopathy: Furthermore, Zheng et al. [76] demonstrated that arsenic trioxide (ATO) upregulates VDAC expression and dimerization, resulting in a reduction of mitochondrial membrane potential (ΔΨm) and an increase of MM cell apoptosis through cytochrome c release.